Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Nephros (NEPH) Capital Expenditures (2016 - 2022)

Nephros has reported Capital Expenditures over the past 6 years, most recently at $103000.0 for Q2 2022.

Quarterly results put Capital Expenditures at $103000.0 for Q2 2022, changed N/A from a year ago — trailing twelve months through Sep 2024 was $103000.0 (changed N/A YoY), and the annual figure for FY2024 was $55000.0, down 26.67%.
Capital Expenditures for Q2 2022 was $103000.0 at Nephros, up from $34000.0 in the prior quarter.
Over the last five years, Capital Expenditures for NEPH hit a ceiling of $103000.0 in Q2 2022 and a floor of $13000.0 in Q3 2020.
Median Capital Expenditures over the past 3 years was $23000.0 (2021), compared with a mean of $37200.0.
Biggest five-year swings in Capital Expenditures: changed 0.0% in 2021 and later skyrocketed 47.83% in 2022.
Nephros' Capital Expenditures stood at $13000.0 in 2020, then changed by 0.0% to $13000.0 in 2021, then skyrocketed by 692.31% to $103000.0 in 2022.
The last three reported values for Capital Expenditures were $103000.0 (Q2 2022), $34000.0 (Q1 2022), and $13000.0 (Q3 2021) per Business Quant data.